Envista Insider Trades
NYSE: NVSTHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 3 · $510.25K
- Shares bought / sold
- 0 / 17.68K
- Net activity
- Net selling $510,250
Envista insider activity
Over the last 12 months, Envista insiders reported 35 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $510,250 worth of stock, for net insider selling of $510,250. The largest seller was Reis Mischa, with $510,250 in reported sales.
The most recent filing shows Keel Paul A (Chairman and CEO) reporting a transaction in 54,197 shares at $23.51 on Nov 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NVST's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NVST insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 1, 2026 | Keel Paul AChairman and CEO | Tax withholding | 54,197 | $1.27M | Form 4 |
| Aug 25, 2026 | Hammes Eric D.Chief Financial Officer | Tax withholding | 10,885 | $299.01K | Form 4 |
| Aug 25, 2026 | Nilsson StefanPresident, Nobel Biocare | Tax withholding | 804 | $22.09K | Form 4 |
| Aug 25, 2026 | Befidi RobertPresident, Diagnostics | Tax withholding | 5,147 | $141.39K | Form 4 |
| Aug 25, 2026 | Acurio VeronicaPresident, Orthodontics | Tax withholding | 7,710 | $211.79K | Form 4 |
| Aug 20, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 8,000 | $220.00K | Form 4 |
| Aug 18, 2026 | Keel Paul AChief Executive Officer | Award | 179,730 | — | Form 4 |
| May 25, 2026 | Keel Paul AChief Executive Officer | Tax withholding | 12,811 | $300.16K | Form 4 |
| May 19, 2026 | Huennekens R ScottDirector | Award | 12,585 | — | Form 4 |
| May 19, 2026 | Raskas DanielDirector | Award | 9,330 | — | Form 4 |
| May 19, 2026 | GALLAHUE KIERANDirector | Award | 9,330 | — | Form 4 |
| May 19, 2026 | Jain VivekDirector | Award | 9,330 | — | Form 4 |
| May 19, 2026 | TSINGOS CHRISTINE ADirector | Award | 9,330 | — | Form 4 |
| May 19, 2026 | Pierce James AndrewDirector | Award | 9,330 | — | Form 4 |
| May 19, 2026 | Carruthers WendyDirector | Award | 9,330 | — | Form 4 |
| Feb 25, 2026 | Befidi RobertPresident, Diagnostics | Award | 7,605 | — | Form 4 |
| Feb 25, 2026 | Befidi RobertPresident, Diagnostics | Tax withholding | 2,177 | $64.42K | Form 4 |
| Feb 25, 2026 | Keel Paul AChief Executive Officer | Award | 48,670 | — | Form 4 |
| Feb 25, 2026 | Keel Paul AChief Executive Officer | Tax withholding | 11,840 | $350.35K | Form 4 |
| Feb 25, 2026 | Kaabi Faez CChief Accounting Officer | Award | 13,520 | — | Form 4 |
| Feb 25, 2026 | Kaabi Faez CChief Accounting Officer | Tax withholding | 4,964 | $146.88K | Form 4 |
| Feb 25, 2026 | Nilsson StefanPresident, Nobel Biocare | Award | 7,605 | — | Form 4 |
| Feb 25, 2026 | Nilsson StefanPresident, Nobel Biocare | Tax withholding | 182 | $5.39K | Form 4 |
| Feb 25, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Award | 5,915 | — | Form 4 |
| Feb 25, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Tax withholding | 2,976 | $88.06K | Form 4 |
| Feb 25, 2026 | Acurio VeronicaPresident, Orthodontics | Award | 7,605 | — | Form 4 |
| Feb 25, 2026 | Acurio VeronicaPresident, Orthodontics | Tax withholding | 1,412 | $41.78K | Form 4 |
| Feb 25, 2026 | Nance Mark EGeneral Counsel | Award | 12,675 | — | Form 4 |
| Feb 25, 2026 | Nance Mark EGeneral Counsel | Tax withholding | 3,368 | $99.66K | Form 4 |
| Feb 25, 2026 | Hammes Eric D.Chief Financial Officer | Award | 16,055 | — | Form 4 |
| Feb 25, 2026 | Hammes Eric D.Chief Financial Officer | Tax withholding | 2,045 | $60.51K | Form 4 |
| Feb 10, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 5,634 | $169.02K | Form 4 |
| Feb 10, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Option exercise | 5,634 | $89.97K | Form 4 |
| Feb 10, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 4,041 | $121.23K | Form 4 |
| Feb 10, 2026 | Reis MischaSVP, Strategy & Bus. Dev. | Option exercise | 4,041 | $76.94K | Form 4 |
| Nov 1, 2025 | Keel Paul AChief Executive Officer | Tax withholding | 54,097 | $1.10M | Form 4 |
| Aug 25, 2025 | Reis MischaSVP, Strategy & Bus. Dev. | Sale | 15,000 | $324.00K | Form 4 |
| Aug 25, 2025 | Acurio VeronicaPresident, Orthodontics | Tax withholding | 5,422 | $114.51K | Form 4 |
| Aug 25, 2025 | Hammes Eric D.Chief Financial Officer | Tax withholding | 7,654 | $161.65K | Form 4 |
| Aug 25, 2025 | Befidi RobertPresident, Diagnostics | Tax withholding | 3,454 | $72.95K | Form 4 |
| Aug 25, 2025 | Nilsson StefanPresident, Nobel Biocare | Tax withholding | 804 | $16.98K | Form 4 |
| Jul 14, 2025 | Pierce James AndrewDirector | Award | 9,155 | — | Form 4 |
| Jun 10, 2025 | Raskas DanielDirector | Award | 10,450 | — | Form 4 |
| Jun 10, 2025 | GALLAHUE KIERANDirector | Award | 10,450 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4